Jupiter Neurosciences Inc (JUNS)

$1.12 -0.06 (-5.08%)
Market Cap 38.56M
Revenue (ttm) 0.00
Net Income (ttm) -2.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 42,200
Avg Vol 100,996
Day's Range N/A - N/A
Shares Out 34.43M
Stochastic %K 11%
Beta N/A
Analysts Sell
Price Target $25.00

Company Profile

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation. The company develops JNS101, which is in Phase II trial for the treatment of Friedreich's Ataxia, a rare inherited disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS108 that is in Phase II trial for treating mild cognitive impairment/early Alzheimer's disease. It is also involved in t...

Industry: Biotechnology
Sector: Healthcare
Phone: 561 406 6154
Address:
1001 North US Highway 1, Suite 504, Jupiter, United States
Thebullrun
Thebullrun Dec. 11 at 3:49 PM
$JUNS let’s rock n roll!!
0 · Reply
FORMER
FORMER Dec. 10 at 10:10 AM
$JUNS On 7/1 Institutional Shares were 400,382 - 1.21% and today (12/10) Institutional Shares are now 1,369,252 - 3.98% 🤙
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 9 at 6:49 PM
$JUNS Jupiter Neurosciences, on - HOT HOT PENNY https://investorshangout.com/post/view?id=6806030
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 9 at 3:07 PM
BB's Stock Haven : $JUNS Jupiter Neurosciences, on https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177042124 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 9 at 1:43 PM
$JUNS Jupiter Neurosciences, on #NASDAQ, just received #FDA Clearance for its IND application JOTROL https://www.youtube.com/watch?v=_-2p4LWhoOw #Stockstobuy #stockstowatch #JUNS #TeamHighAlert @Charles
0 · Reply
WallStpolitician
WallStpolitician Dec. 9 at 1:34 AM
$JUNS did a non deal roadshow in NYC today, after a successful Noble Con conference in Ft Lauderdale last week 🚀🚀🚀
0 · Reply
Thebullrun
Thebullrun Dec. 9 at 12:31 AM
$JUNS
0 · Reply
Ichigodoran
Ichigodoran Dec. 8 at 2:59 PM
$JUNS News : Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum https://finance.yahoo.com/news/jupiter-neurosciences-marks-transformational-first-130000175.html
0 · Reply
Ichigodoran
Ichigodoran Dec. 5 at 5:35 PM
$JUNS Jupiter Neurosciences, #JUNS on #NASDAQ, just received #FDA Clearance for its IND application JOTROL https://youtu.be/_-2p4LWhoOw?si=jw1c8UGHI-v2h5xx
0 · Reply
Ichigodoran
Ichigodoran Dec. 5 at 11:52 AM
$JUNS : Jupiter Neurosciences: Advancing World-Class Neuro Therapies with $50B+ Market Potential https://www.youtube.com/watch?v=ohMasK_hxjw
0 · Reply
Latest News on JUNS
Jupiter Neurosciences to Participate in NobleCon21

Dec 2, 2025, 4:15 PM EST - 11 days ago

Jupiter Neurosciences to Participate in NobleCon21

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

Oct 27, 2025, 8:30 AM EDT - 6 weeks ago

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

Aug 19, 2025, 8:12 AM EDT - 4 months ago

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jul 23, 2025, 8:00 AM EDT - 5 months ago

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 10, 2025, 4:05 PM EDT - 5 months ago

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jun 30, 2025, 3:15 PM EDT - 5 months ago

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jun 23, 2025, 8:00 AM EDT - 6 months ago

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Feb 4, 2025, 9:25 AM EST - 11 months ago

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jan 30, 2025, 8:00 AM EST - 11 months ago

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Dec 4, 2024, 4:56 PM EST - 1 year ago

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Dec 2, 2024, 7:00 PM EST - 1 year ago

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO

Aug 16, 2022, 5:48 PM EDT - 3 years ago

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO

Thebullrun
Thebullrun Dec. 11 at 3:49 PM
$JUNS let’s rock n roll!!
0 · Reply
FORMER
FORMER Dec. 10 at 10:10 AM
$JUNS On 7/1 Institutional Shares were 400,382 - 1.21% and today (12/10) Institutional Shares are now 1,369,252 - 3.98% 🤙
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 9 at 6:49 PM
$JUNS Jupiter Neurosciences, on - HOT HOT PENNY https://investorshangout.com/post/view?id=6806030
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 9 at 3:07 PM
BB's Stock Haven : $JUNS Jupiter Neurosciences, on https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177042124 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 9 at 1:43 PM
$JUNS Jupiter Neurosciences, on #NASDAQ, just received #FDA Clearance for its IND application JOTROL https://www.youtube.com/watch?v=_-2p4LWhoOw #Stockstobuy #stockstowatch #JUNS #TeamHighAlert @Charles
0 · Reply
WallStpolitician
WallStpolitician Dec. 9 at 1:34 AM
$JUNS did a non deal roadshow in NYC today, after a successful Noble Con conference in Ft Lauderdale last week 🚀🚀🚀
0 · Reply
Thebullrun
Thebullrun Dec. 9 at 12:31 AM
$JUNS
0 · Reply
Ichigodoran
Ichigodoran Dec. 8 at 2:59 PM
$JUNS News : Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum https://finance.yahoo.com/news/jupiter-neurosciences-marks-transformational-first-130000175.html
0 · Reply
Ichigodoran
Ichigodoran Dec. 5 at 5:35 PM
$JUNS Jupiter Neurosciences, #JUNS on #NASDAQ, just received #FDA Clearance for its IND application JOTROL https://youtu.be/_-2p4LWhoOw?si=jw1c8UGHI-v2h5xx
0 · Reply
Ichigodoran
Ichigodoran Dec. 5 at 11:52 AM
$JUNS : Jupiter Neurosciences: Advancing World-Class Neuro Therapies with $50B+ Market Potential https://www.youtube.com/watch?v=ohMasK_hxjw
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 6:57 PM
$JUNS Jupiter Neurosciences Marks - Xtremepicks Alerts https://investorshangout.com/post/view?id=6805266
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 4:42 PM
$JUNS Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum https://www.stocktitan.net/news/JUNS/jupiter-neurosciences-marks-transformational-first-year-as-a-public-eifyvcbzedsi.html
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 3:14 PM
MOMO'S BREAKOUT BOARD : $JUNS Jupiter Neurosciences Marks Transf... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177024278 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 4 at 2:06 PM
$JUNS Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum https://www.stocktitan.net/news/JUNS/jupiter-neurosciences-marks-transformational-first-year-as-a-public-eifyvcbzedsi.html #Stockstobuy #stockstowatch #JUNS #TeamHighAlert
0 · Reply
Ichigodoran
Ichigodoran Dec. 3 at 1:46 PM
$JUNS Breaking News : Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum https://finance.yahoo.com/news/jupiter-neurosciences-marks-transformational-first-130000175.html
0 · Reply
Ichigodoran
Ichigodoran Dec. 3 at 1:23 PM
$JUNS December Investor Presentation https://redchip.com/stocks/JUNS
0 · Reply
newsfile_corp
newsfile_corp Dec. 2 at 9:16 PM
https://nfne.ws/276669 $JUNS #Banking #FinancialServices #NASDAQ #Investing
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 2 at 5:39 PM
Jupiter Neurosciences, $JUNS on #NASDAQ, just received #FDA Clearance for its IND application JOTROL https://www.reddit.com/user/Typical-Stay4553/comments/1pcefz1/jupiter_neurosciences_juns_on_nasdaq_just/
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 2 at 2:37 PM
Jupiter Neurosciences Inc ( $JUNS ): Exciting news from the biotech world! Ju... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177014128 via @Investors_Hub
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 2 at 1:51 PM
Exciting news from the biotech world! Jupiter Neurosciences, Inc. ( $JUNS on #NASDAQ), a clinical-stage pharmaceutical company focused on addressing neuroinflammation and promoting healthy aging, has just received #FDA Clearance for its IND application to kick off a Phase 2a clinical trial of #JOTROL™ in Parkinson’s disease. https://www.youtube.com/watch?v=_-2p4LWhoOw #Stockstobuy #stockstowatch #JUNS #TeamHighAlert @Charles
0 · Reply
SmallCapGrowth
SmallCapGrowth Dec. 2 at 1:47 PM
Exciting news from the biotech world! Jupiter Neurosciences, Inc. ( $JUNS on #NASDAQ), a clinical-stage pharmaceutical company focused on addressing neuroinflammation and promoting healthy aging, has just received #FDA Clearance for its IND application to kick off a Phase 2a clinical trial of #JOTROL™ in Parkinson’s disease. https://www.youtube.com/watch?v=_-2p4LWhoOw #Stockstobuy #stockstowatch #JUNS #TeamHighAlert @Charles
0 · Reply
Ichigodoran
Ichigodoran Dec. 1 at 1:39 PM
$JUNS Bull Run - Jupiter Neurosciences, #JUNS on #NASDAQ, just received #FDA Clearance for its IND application JOTROL https://youtu.be/_-2p4LWhoOw?si=i4R-NA2nNe9kVPX8
0 · Reply